|1.||Roos, D: 4 articles (04/2009 - 01/2000)|
|2.||de Boer, M: 2 articles (04/2009 - 01/2000)|
|3.||Roos, Dirk: 2 articles (03/2004 - 06/2003)|
|4.||Fieschi, Franck: 1 article (12/2014)|
|5.||Grunwald, Didier: 1 article (12/2014)|
|6.||Beaumel, Sylvain: 1 article (12/2014)|
|7.||Stasia, Marie José: 1 article (12/2014)|
|8.||Yamada, Masafumi: 1 article (04/2012)|
|9.||Kawamura, Nobuaki: 1 article (04/2012)|
|10.||Suzuki, Yasuto: 1 article (04/2012)|
|1.||Chronic Granulomatous Disease
03/01/1995 - "In this study, we examined the accumulation of 4-HNE-protein adducts in phagosomes of neutrophils obtained from a male patient with homozygous X-linked, flavocytochrome b-deficient chronic granulomatous disease (CGD), his heterozygous mother, and his normal father. "
12/15/2014 - "We reproduced 10 rare X-minus chronic granulomatous disease (CGD) mutations of highly conserved residues in NOX1-NOX4, in X0-CGD PLB-985 cells in order to analyse their impact on the synthesis of cytochrome b558. "
04/10/2012 - "X-linked chronic granulomatous disease (X-CGD) is a primary immunodeficiency disease of phagocytes caused by mutations in the cytochrome b(558)β (CYBB) gene. "
02/01/2007 - "In chronic granulomatous disease, neutrophils have lost their bactericidal capacity The most frequent form is hereditary and X-linked; in this case, the affected gene is CYBB, which encodes gp91-phox, the catalytic subunit of cytochrome b558. "
01/01/2001 - "These results localized the epitope of 7D5 to an extracellular peptide portion of primate gp91phox and indicate that the antibody will be useful for monitoring the efficiency of gene therapy in patients with flavocytochrome b558-deficient chronic granulomatous disease and for elucidating structural characteristics of flavocytochrome b558."
|4.||Non-Hodgkin Lymphoma (Lymphosarcoma)
11/01/1993 - "Among the 55 B-MLs, all follicular lymphomas (9/9) and 18/46 of the diffuse lymphomas were found to express cytochrome b558. "
05/01/2011 - "Proline rich polypeptide (PRP-1) increases the superoxide-producing and ferrihemoglobin reducing activities of cytochrome B(558) isoforms from human lymphosarcoma tissue cells."
|2.||Reactive Oxygen Species (Oxygen Radicals)
|4.||NADPH Oxidase (NAD(P)H oxidase)
|6.||4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)
|7.||Cytochromes b (Cytochrome b)
|10.||neutrophil cytosol factor 67K